I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Orsini‐Piocelle, Frédérique
54
results:
Search for persons
X
Format
Online (54)
Mediatypes
Articles (Online) (12)
OpenAccess-fulltext (42)
Sorted by: Relevance
Sorted by: Year
?
1
Increased risk of infection reporting with anti‐BCMA bispec..:
Contejean, Adrien
;
Janssen, Cécile
;
Orsini‐Piocelle, Frédérique
...
American Journal of Hematology. 98 (2023) 12 - p. , 2023
Link:
https://doi.org/10.1002/..
?
2
Adverse outcome in follicular lymphoma is associated with M..:
Bussot, Lucile
;
Chevalier, Simon
;
Cristante, Justine
...
British Journal of Haematology. 194 (2021) 2 - p. 382-392 , 2021
Link:
https://doi.org/10.1111/..
?
3
Apixaban for the prevention of thromboembolism in immunomod..:
Pegourie, Brigitte
;
Karlin, Lionel
;
Benboubker, Lotfi
...
American Journal of Hematology. 94 (2019) 6 - p. 635-640 , 2019
Link:
https://doi.org/10.1002/..
?
4
Bortezomib, thalidomide, and dexamethasone with or without ..:
Moreau, Philippe
;
Hulin, Cyrille
;
Perrot, Aurore
...
The Lancet Oncology. , 2024
Link:
https://doi.org/10.1016/..
?
5
Isatuximab, lenalidomide, dexamethasone and bortezomib in t..:
Leleu, Xavier
;
Hulin, Cyrille
;
Lambert, Jerome
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
6
A fixed-duration immunochemotherapy approach in CLL: 5.5-ye..:
Michallet, Anne-Sophie
;
Letestu, Rémi
;
Le Garff-Tavernier, Magali
...
Blood Advances. 7 (2023) 15 - p. 3936-3945 , 2023
Link:
https://doi.org/10.1182/..
?
7
Heterogeneity in long-term outcomes for patients with Revis..:
Schavgoulidze, Anais
;
Lauwers-Cances, Valerie
;
Perrot, Aurore
...
Haematologica. 108 (2022) 5 - p. 1374-1384 , 2022
Link:
https://doi.org/10.3324/..
?
8
OAB-016: High risk subclones detected at relapse are presen..:
Lannes, Romain
;
Samur, Mehmet
;
Perrot, Aurore
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S10 , 2022
Link:
https://doi.org/10.1016/..
?
9
Clinicopathological features and survival in EBV-positive d..:
Bourbon, Estelle
;
Maucort-Boulch, Delphine
;
Fontaine, Juliette
...
Blood Advances. 5 (2021) 16 - p. 3227-3239 , 2021
Link:
https://doi.org/10.1182/..
?
10
Improved survival in multiple myeloma during the 2005–2009 ..:
Corre, Jill
;
Perrot, Aurore
;
Hulin, Cyrille
...
Leukemia. 35 (2021) 12 - p. 3600-3603 , 2021
Link:
https://doi.org/10.1038/..
?
11
Early relapse after autologous transplant for myeloma is as..:
Corre, Jill
;
Montes, Lydia
;
Martin, Elodie
...
Haematologica. 105 (2020) 9 - p. e480-483 , 2020
Link:
https://doi.org/10.3324/..
?
12
Bortezomib, thalidomide, and dexamethasone with or without ..:
Moreau, Philippe
;
Attal, Michel
;
Hulin, Cyrille
...
The Lancet. 394 (2019) 10192 - p. 29-38 , 2019
Link:
https://doi.org/10.1016/..
?
13
Heterogeneity in long-term outcomes for patients with Revis..:
Schavgoulidze, Anais
;
Lauwers-Cances, Valérie
;
Perrot, Aurore
...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023
Link:
https://u-picardie.hal.s..
?
14
Heterogeneity in long-term outcomes for patients with Revis..:
Schavgoulidze, Anais
;
Lauwers-Cances, Valérie
;
Perrot, Aurore
...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023
Link:
https://u-picardie.hal.s..
?
15
Heterogeneity in long-term outcomes for patients with Revis..:
Schavgoulidze, Anais
;
Lauwers-Cances, Valérie
;
Perrot, Aurore
...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023
Link:
https://u-picardie.hal.s..
1-15
